Elevated carcinoembryonic antigen levels and biliary tract obstruction.

Area of Science:

• Hepatology
• Gastroenterology
• Oncology

Background:

• Elevated carcinoembryonic antigen (CEA) is often associated with malignancy.
• Benign conditions, such as biliary tract obstruction, can also affect CEA levels.
• Understanding CEA behavior in benign liver disease is crucial for accurate diagnosis.

Purpose of the Study:

• To investigate the relationship between circulating carcinoembryonic antigen (CEA) levels and liver function tests in patients with benign extrahepatic biliary tract obstruction.
• To determine if elevated CEA levels in jaundiced patients are indicative of malignancy or benign conditions.

Main Methods:

• Studied 29 jaundiced patients with benign extrahepatic biliary tract obstruction and inflammation.
• Measured circulating carcinoembryonic antigen (CEA) levels.
• Assessed liver function tests, including serum alkaline phosphatase and bilirubin.
• Monitored CEA levels before and after relief of obstruction.

Main Results:

• 52% of patients had elevated CEA levels (>2.5 ng/ml) during obstruction.
• Elevated CEA was more frequent with common bile duct stones and cholangitis than gallbladder stones and cholecystitis.
• Serum alkaline phosphatase and bilirubin levels were significantly higher in patients with elevated CEA.
• CEA levels normalized in 70% of patients after obstruction relief.

Conclusions:

• Elevated circulating carcinoembryonic antigen (CEA) levels in jaundiced patients can be associated with benign biliary tract obstruction and inflammation.
• CEA levels correlate with liver function test abnormalities in these patients.
• Elevated CEA in the context of obstructive jaundice does not necessarily imply cancer, highlighting the importance of clinical context.